BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25136067)

  • 1. PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer.
    Yao R; Jiang H; Ma Y; Wang L; Wang L; Du J; Hou P; Gao Y; Zhao L; Wang G; Zhang Y; Liu DX; Huang B; Lu J
    Cancer Res; 2014 Oct; 74(19):5656-67. PubMed ID: 25136067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automethylation of protein arginine methyltransferase 7 and its impact on breast cancer progression.
    Geng P; Zhang Y; Liu X; Zhang N; Liu Y; Liu X; Lin C; Yan X; Li Z; Wang G; Li Y; Tan J; Liu DX; Huang B; Lu J
    FASEB J; 2017 Jun; 31(6):2287-2300. PubMed ID: 28188177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression.
    Baldwin RM; Haghandish N; Daneshmand M; Amin S; Paris G; Falls TJ; Bell JC; Islam S; Côté J
    Oncotarget; 2015 Feb; 6(5):3013-32. PubMed ID: 25605249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
    Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
    J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling.
    Li Y; Ke Q; Shao Y; Zhu G; Li Y; Geng N; Jin F; Li F
    Oncotarget; 2015 Feb; 6(6):4345-56. PubMed ID: 25726523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling.
    Liu Y; Li L; Liu X; Wang Y; Liu L; Peng L; Liu J; Zhang L; Wang G; Li H; Liu DX; Huang B; Lu J; Zhang Y
    Elife; 2020 Aug; 9():. PubMed ID: 32844749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
    Wang X; Zheng M; Liu G; Xia W; McKeown-Longo PJ; Hung MC; Zhao J
    Cancer Res; 2007 Aug; 67(15):7184-93. PubMed ID: 17671186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.
    Latorre E; Carelli S; Raimondi I; D'Agostino V; Castiglioni I; Zucal C; Moro G; Luciani A; Ghilardi G; Monti E; Inga A; Di Giulio AM; Gorio A; Provenzani A
    Cancer Res; 2016 May; 76(9):2626-36. PubMed ID: 27197265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
    J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK; Lee DS; Park JC
    BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
    Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
    Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
    Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
    J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.